1. Treatment of refractory heart failure with infusion of nitroprusside;Guiha, N.H.; Cohn, J.N.; Mikulic, E.; Franciosa, J.A.; Limas, C.J.;N EnglJ Med,1974
2. Hydrlazine in the management of left ventricular failure;Fitchett, D.H.I.; Marin-Neto, J.A.; Oakley, C.M.; Goodwin, J.F.;Am J Cardiol,1979
3. Hemodynamic characterization of tolerance to long-term hydralazine therapy in severe chronic heart failure;Packer, M.; Meller, J.; Medina, N.; Yushak, M.; Gorlin, R.;N EnglJ Med,1982
4. Oral hydrlaine in chronic heart failure: sustained beneficial hemodynamic effects;Chatterjee, K.; Ports, T.A.; Brundage, S.H.; Massie, B.; Holly, A.N.; Parmley, W.W.;Ann Intern. Mcd,1980
5. Hemodynamic assessment of oral peripheral vasodilator therapy in chronic congestive heart failure: prolonged effectiveness of isosorbide dinitrate;Wiliams, D.O.; Bommer, W.J.; Miller, R.R.; Amsterdam, E.A.; Mason, D.T.;Am J Cardiol,1977